BioSpace News Archive

Business

Stryker declares a $0.695 per share quarterly dividend

Stryker announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable January 31, 2022 to shareholders of record at the close of business on December 31, 2021, representing an increase of 10.3% versus the prior year and previous quarter.

December 9, 2021
·
1 min read
FDA

Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF®

Heron Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam) extended-release solution to significantly expand the indication.

December 9, 2021
·
8 min read
The innovative software “CAAS vFFR” by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness

Pie Medical Imaging, a global leader in cardiac imaging, part of the Esaote Group, announced the beginning of FASTIII, a multicenter randomized clinical trial which will investigate the use of angiography-based vessel fractional flow reserve in patients undergoing coronary revascularization procedures.

December 9, 2021
·
2 min read
Drug Development

Iterion Therapeutics Announces Initiation of Phase 1 Clinical Trial to Study Tegavivint in Combination with Osimertinib in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

Iterion Therapeutics, Inc., a venture-backed, clinical-stage

December 9, 2021
·
5 min read
Delic Corp Announces Participation Details For January 2022 Investor Conferences

Delic Holdings Corp today announced details regarding Matt Stang, co-founder and CEO of Delic, and his participation at the upcoming HC Wainwright Bioconnect Virtual Conference and CEM’s 8th annual AlphaNorth Capital Conference in January.

December 9, 2021
·
7 min read
Business

Karius Prepares for Further Growth with New Chief Financial Officer, Chief Legal Officer Appointments

Karius, the world leader in liquid biopsy for infectious diseases, announced the addition of two key executives to best position the company for continued growth.

December 9, 2021
·
3 min read
Business

Inspirna Strengthens Scientific Advisory Board with Two Globally Renowned Experts in Gastrointestinal Oncology

Inspirna, Inc. announced today the appointment of Josep Tabernero, M.D., Ph.D. and Alan P. Venook, M.D., to its scientific advisory board.

December 9, 2021
·
4 min read
Biotech Beach

Dermavant Announces Publication of PSOARING 1 & 2 Pivotal Studies of Tapinarof in Plaque Psoriasis in The New England Journal of Medicine

Dermavant Announces Publication of PSOARING 1 & 2 Pivotal Studies of Tapinarof in Plaque Psoriasis in The New England Journal of Medicine.

December 9, 2021
·
5 min read
Biotech Beach

Biocept’s CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations in Patients with Breast Cancer that has Metastasized to the Brain

Biocept, Inc presented a study demonstrating the ability of its CNSide™ assay to identify HER2 and other actionable tumor alterations in the cerebrospinal fluid of patients with breast cancer and leptomeningeal disease (LMD).

December 9, 2021
·
5 min read
Drug Development

Vir Biotechnology Announces Initiation of Phase 2 Clinical Trial Evaluating VIR-2218, Selgantolimod and Nivolumab for the Treatment of Chronic Hepatitis B Virus Infection

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating novel therapeutic combinations for the treatment of chronic hepatitis B virus (HBV) infection.

December 9, 2021
·
6 min read